Who owns LAVA THERAPEUTICS NV?
- Ticker: LVTX
- CUSIP Number: n51517105
Tip: Access positions for across all investors
Analyze quarterly positions in Lava Therapeutics Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Lava Therapeutics Nv stock
Who bought or sold LAVA THERAPEUTICS NV this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Novo A/S | 2.4M | $3.5M | 0% | Sep 2023 |
|
Redmile Group | 2.1M | $3.3M | 0% | Dec 2023 |
|
Tang Capital Management | 841k | $1.3M | 100% | Dec 2023 |
|
Bruce & Co | 772k | $1.2M | 0% | Dec 2023 |
|
Falcon Edge Capital | 109k | $163k | 0% | Sep 2023 |
|
Pnc Financial Services | 65k | $103k | 0% | Dec 2023 |
|
Millennium Management | 28k | $44k | -56% | Dec 2023 |
|
Citadel Advisors | 22k | $34k | 100% | Dec 2023 |
|
Susquehanna International | 17k | $25k | -1% | Sep 2023 |
|
Tower Research Capital | 12k | $18k | 0% | Sep 2023 |
|
Geode Capital Management | 11k | $17k | 0% | Sep 2023 |
|
Morgan Stanley | 10k | $15k | 1% | Sep 2023 |
|
Simplex Trading | 440.00 | $0 | -35% | Dec 2023 |
|
TSFG | 400.00 | $1.0k | 0% | Dec 2023 |
|
Group One Trading | 100.00 | $149.000000 | 0% | Sep 2023 |
|
Who sold out of Lava Therapeutics Nv?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Artal Group | Sep 2023 | 200k | $294k |